Immunome Inc.

6.71
0.45 (7.19%)
At close: Apr 02, 2025, 3:59 PM
6.68
-0.37%
After-hours: Apr 02, 2025, 05:20 PM EDT

Immunome Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue 9.04M 14.02M n/a n/a n/a n/a n/a
Cost of Revenue n/a 22.93M 631K 755K 755K 615K 521K
Gross Profit 9.04M -8.91M -631K -755K -755K -615K -521K
Operating Income -305.8M -109.53M -36.9M -25.2M -12.26M -10.35M -7.74M
Interest Income 12.84M 2.72M 5K 10K 1K 10K 39K
Pretax Income -292.96M -106.81M -36.9M -24.71M -17.84M -10.44M -7.84M
Net Income -292.96M -106.81M -37.51M -24.47M -17.12M -10.55M -7.84M
Selling & General & Admin 32.95M 19.66M 13.63M 11.09M 4.78M 1.52M 866K
Research & Development 152.34M 103.16M 23.27M 14.11M 7.49M 8.82M 6.88M
Other Expenses 129.54M n/a n/a 503K n/a n/a n/a
Operating Expenses 314.84M 122.82M 36.9M 25.2M 12.26M 10.35M 7.74M
Interest Expense n/a n/a 5K 10K 38K 106K 141K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 314.84M 123.55M 36.9M 25.2M 12.26M 10.35M 7.74M
Income Tax n/a n/a 617K -242K -717K 106K 39K
Shares Outstanding (Basic) 58.64M 19.84M 12.13M 11.54M 10.11M 5.74M 1.09M
Shares Outstanding (Diluted) 58.64M 19.84M 12.13M 11.54M 10.11M 5.74M 1.09M
EPS (Basic) -5 -5.38 -3.09 -2.12 -1.69 -1.84 -7.18
EPS (Diluted) -5 -5.38 -3.09 -2.12 -1.69 -1.84 -7.18
EBITDA -151.35M -28.27M -36.27M -23.95M -17.04M -9.72M -7.18M
EBIT -153.46M -28.73M -36.9M -24.7M -17.8M -10.34M -7.7M
Depreciation & Amortization 2.1M 728K 631K 755K 755K 615K 521K